eSMART: Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers

Study code 
Device Trial in Breast, Colorectal and Haematological Cancer

The eSMART project aims to demonstrate benefits for cancer patients using a real-time, mobile phone based remote patient monitoring system, the Advanced Symptom Management System (ASyMS). It is anticipated to greatly improve patient outcomes and delivery of care both during and after chemotherapy treatment.

The eSMART project involves 11 European and 1 American partner as well as cancer care clinicians from all partner countries. A trial will be conducted across 16 European sites with 1108 patients being recruited. Patients will be invited onto the trial, with eligibility determined by a) undergoing their first course of chemotherapy, b) for breast, colorectal or haematological cancers and c) planning to receive a minimum of 4 cycles of chemotherapy. The project is being advised by members of the European Cancer Patient Coalition to ensure that work is conducted in line with patients’ perspectives and needs.


Trim content